Raze Therapeutics, with breakthrough discoveries utilizing functional genomics, metabolomics and computational biology from Raze Therapeutics Founders’ labs, is developing novel anti-tumor agents by targeting the key pathway of mitochondrial one-carbon metabolism that drives biomass production required for rapid proliferation of tumor cells.

razetx.com/